Brez internetne povezave — prikazana je shranjena različica strani.

Agios Pharm

USUSD
← Na filter delnic

Agios Pharm (US:AGIO) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O podjetju

Spletna stran
agios.com
Odnosi z vlagatelji
investor.agios.com/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
Cambridge, United States
Izvršni direktor
Mr. Brian M. Goff M.B.A.
Zaposleni
539
Ustanovljena
2008
Delnice v obtoku
59.7 mio. na dan 2026-07-24
Prosto prenosljive delnice
50.02 mio.
Tržna kapitalizacija
2 mrd. USD
Notranje osebe
1.07%
Institucionalni vlagatelji
112.31%
Panoga (SIC)
Pharmaceutical Preparations
ISIN
US00847X1046
LEI
529900ONJHY8EOGYT555
Opis

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Borze in oznake

BorzaOznakaValutaCenaVrsta
US USA StocksAGIO glavnaUSD31.72 +1.50%navadne delnice
LSE London Stock Exchange0HB0 IOBUSD33.1105 +0.00%navadne delnice

Cena v 3 mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Ni bilo najdenih izplačil dividend (preverjeno 08.10.2026). Podjetje verjetno ne izplačuje dividend.

Novice ta teden

Novic s spletnega mesta podjetja še ni.

oglas

Največji imetniki

ImetnikDeležDelniceDatum poročila
Blackrock Inc.10.81%6.46 mio.2026-06-30
Farallon Capital Managem…9.91%5.92 mio.2026-06-30
State Street Corporation5.92%3.53 mio.2026-06-30
Lynx1 Capital Management…5.71%3.41 mio.2026-06-30
Shaw D.E. & Co., Inc.5.2%3.11 mio.2026-06-30
Vanguard Portfolio Manag…4.85%2.9 mio.2026-06-30
Vanguard Capital Managem…4.49%2.68 mio.2026-06-30
Armistice Capital, LLC4.02%2.4 mio.2026-06-30
Erste Asset Management G…3.61%2.15 mio.2026-06-30
SPDR SERIES TRUST-State…3.54%2.11 mio.2026-08-31
Nomura Asset Management…3.54%2.11 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.16%1.89 mio.2026-06-30
iShares Trust-iShares Ru…2.52%1.51 mio.2026-07-31
VANGUARD INDEX FUNDS-Van…2.28%1.36 mio.2026-06-30
Delaware Group Equity Fu…1.92%1.14 mio.2026-05-31
VANGUARD INDEX FUNDS-Van…1.32%788 6552026-06-30
VANGUARD INDEX FUNDS-Van…1.15%683 9902026-06-30
Fidelity Salem Street Tr…1.08%646 3182026-07-31
Fidelity Rutland Square…0.88%526 1212026-07-31
iShares Trust-iShares Ru…0.86%511 9942026-07-31
FOUSE JACQUALYN A. (Dire…≈0.26%154 1562026-06-18
GHEUENS SARAH (Officer)≈0.09%54 6452026-08-04
SCADDEN DAVID T. (Direct…≈0.03%20 4192026-06-18
HO MAYKIN (Director)≈0.03%19 8482026-06-18
BALLAL RAHUL D. (Directo…≈0.03%15 2302026-06-18
SMITH CYNTHIA (Director)≈0.03%15 2302026-06-18
FOSTER-CHEEK KAYE I (Dir…≈0.02%12 4842026-06-18
ADAMS CATHERINE OWEN (Di…≈0.02%10 8652026-06-18
CAPELLO JEFFREY D (Direc…≈0.02%10 8652026-06-18
BACKSTROM JAY T (Directo…≈0%1 4472026-07-08